scholarly journals Patient outcomes from lung cancer and diabetes mellitus: a matched case–control study

2018 ◽  
Vol 4 (1) ◽  
pp. FSO248 ◽  
Author(s):  
Nina J Karlin ◽  
Shailja B Amin ◽  
Matthew R Buras ◽  
Heidi E Kosiorek ◽  
Patricia M Verona ◽  
...  
2019 ◽  
Vol 2019 ◽  
pp. 1-9 ◽  
Author(s):  
Xīn Gào ◽  
Yang Xuan ◽  
Axel Benner ◽  
Ankita Anusruti ◽  
Hermann Brenner ◽  
...  

Studies suggest that nitric oxide (NO) may have a possible role in lung carcinogenesis. This study is aimed to evaluate the association of the NO metabolites, namely, nitrite and nitrate, with lung cancer incidence. We conducted a matched case-control study (n=245 incident lung cancer cases and n=735 controls) based on the German ESTHER cohort (n=9,940). Controls were matched to cases on age, sex, smoking status (never/former/current smoking), and pack-years of smoking. The sum of nitrite and nitrate was measured in urine samples using a colorimetric assay and was standardized for renal function by urinary creatinine. Conditional logistic regression models, adjusted for lifestyle factors, asthma prevalence, and family history of lung cancer, were used to estimate odds ratios (ORs) and 95% confidence intervals (95% CI). Among incident lung cancer cases, high nitrite/nitrate levels were statistically significantly associated with current smoking, a low BMI, and the oxidative stress biomarker 8-isoprostane levels. Nitrite/nitrate levels in the top quintile were statistically significantly associated with lung cancer incidence: the OR (95% CI) was 1.37 (1.04-1.82) for comparison with the bottom quintile. This association was unaltered after additional adjustment for 8-isoprostane levels and C-reactive protein (CRP). In conclusion, this large cohort study suggested that subjects with high urinary nitrite/nitrate concentrations had an increased risk of lung cancer and this association was independent of smoking, CRP, 8-isoprostane levels, and other established lung cancer risk factors. Further studies are needed to validate these findings and to confirm the hypothesis that pathologically high levels of NO are involved in lung cancer development.


2012 ◽  
Vol 24 (3) ◽  
pp. 567-576 ◽  
Author(s):  
Yen-Li Lo ◽  
Chin-Fu Hsiao ◽  
Gee-Chen Chang ◽  
Ying-Huang Tsai ◽  
Ming-Shyan Huang ◽  
...  

2004 ◽  
Vol 21 (9) ◽  
pp. 1035-1040 ◽  
Author(s):  
A. L. Marshall ◽  
A. Chetwynd ◽  
J. A. Morris ◽  
M. Placzek ◽  
C. Smith ◽  
...  

Author(s):  
Eung Joo Park ◽  
Hokyou Lee ◽  
Hyeon Chang Kim ◽  
Seung Soo Sheen ◽  
Sang Baek Koh ◽  
...  

Residential radon exposure and cigarette smoking are the two most important risk factors for lung cancer. The combined effects thereof were evaluated in a multi-center matched case-control study in South Korea. A total of 1038 participants were included, comprising 519 non-small cell lung cancer cases and 519 age- and sex- matched community-based controls. Residential radon levels were measured for all participants. Multivariate logistic regression was used to calculate odds ratios (OR) for lung cancer according to radon exposure (high ≥ 100 Bq/m3 vs. low < 100 Bq/m3), smoking status, and combinations of the two after adjusting for age, sex, indoor hours, and other housing information. The median age of the participants was 64 years, and 51.3% were women. The adjusted ORs (95% confidence intervals [CIs]) for high radon and cigarette smoking were 1.56 (1.03–2.37) and 2.53 (1.60–3.99), respectively. When stratified according to combinations of radon exposure and smoking status, the adjusted ORs (95% CIs) for lung cancer in high-radon non-smokers, low-radon smokers, and high-radon smokers were 1.40 (0.81–2.43), 2.42 (1.49–3.92), and 4.27 (2.14–8.52), respectively, with reference to low-radon non-smokers. Both residential radon and cigarette smoking were associated with increased odds for lung cancer, and the difference in ORs according to radon exposure was much greater in smokers than in non-smokers.


2019 ◽  
Author(s):  
Fatima A Alhussain ◽  
Fahad A Al Eidan ◽  
Sameera Al Johani ◽  
Motasim Badri

Abstract Background Pseudomonas aeruginosa (P.aeruginosa) is a leading nosocomial gram-negative pathogen associated with prolonged hospitalization, morbidity and mortality. Limited data exist regarding P.aeruginosa infection and outcome in patients managed in intensive care units (ICUs). We aimed to determine the risk factors, antimicrobial susceptibility pattern and patient outcomes of P.aeruginosa infection. Methods In this matched case-control study, all P.aeruginosa infections that occurred >48 hours after hospital admission between January 31st 2016 and December 31st 2018 at ICUs affiliated with King Abdulaziz Medical City, Riyadh were included. P.aeruginosa bacilli was confirmed using API 20E test and antimicrobial susceptibility using disk diffusion or Epsilometer test. Results The study included 90 cases and 90 controls. Compared with controls, cases had significantly higher mean ICU stay days, proportions of patients with previous history of antimicrobial therapy, coronary artery disease, malignancy, hemodialysis, previous surgery, use of central line, urethral catheterization, nasogastric tube, and tracheostomy. In a multivariate conditional logistic regression analysis, factors independently associated with P.aeruginosa infection were ICU duration [Odds Ratio (OR)=9.05,95%CI 2.53-32.27, p=.001], previous surgery (OR=7.33,95%CI 1.66-32.36,p=.009), tracheostomy (OR=11.13,95%CI 1.05-118.59,p=.046), urethral catheterization (OR=7.38,95%CI 1.21-45.11,p=.030) and aminoglycoside drug class (OR=10.59,95%CI 1.14-98.13,p=.038). Of antimicrobial drugs used, highest proportion of resistance was calculated for patients receiving tigecycline (93.3%). Mortality was high in both groups but did not differ significantly: 54(60%) cases and 51(56.7%) controls; p=.650. Conclusions: The study identifies several modifiable factors associated with P.aeruginosa infection in ICUs. These factors are of paramount relevance for case identification, control measures, and optimal treatment strategies of P.aeruginosa infection in ICUs.


2019 ◽  
Author(s):  
Eung Joo Park ◽  
Hokyou Lee ◽  
Hyeon Chang Kim ◽  
Seung soo Sheen ◽  
Sang Baek Koh ◽  
...  

Abstract Background: Residential radon exposure and cigarette smoking are the two most important risk factors for lung cancer. The combined effects thereof were evaluated in a multi-center matched case-control study in South Korea.Methods: A total of 1,038 participants were included, comprising 519 non-small cell lung cancer cases and 519 age- and sex- matched community-based controls. Residential radon levels were measured for all participants. Multivariate logistic regression was used to calculate odds ratios (OR) for lung cancer according to radon exposure (high ≥100 Bq/m3 vs. low <100 Bq/m3), smoking status, and combinations of the two after adjusting for age, sex, indoor hours, and other housing information.Results: The median age of the participants was 64 years, and 51.3% were women. The adjusted ORs (95% confidence intervals [CIs]) for high radon and cigarette smoking were 1.56 (1.03-2.37) and 2.53 (1.60-3.99), respectively. When stratified according to combinations of radon exposure and smoking status, the adjusted ORs (95% CIs) for lung cancer in high-radon non-smokers, low-radon smokers, and high-radon smokers were 1.40 (0.81-2.43), 2.42 (1.49-3.92), and 4.27 (2.14-8.52), respectively, with reference to low-radon non-smokers.Conclusion: Both residential radon and cigarette smoking were associated with increased odds for lung cancer, and the difference in ORs according to radon exposure was much greater in smokers than in non-smokers.


Sign in / Sign up

Export Citation Format

Share Document